🇺🇸 FDA
Patent

US 12168023

Inhibitors of adenosine 5′-nucleotidase

granted A61KA61K31/706A61K31/7064

Quick answer

US patent 12168023 (Inhibitors of adenosine 5′-nucleotidase) held by Arcus Biosciences, Inc. expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/706, A61K31/7064, A61K31/7076, A61K39/3955